65 Participants Needed

Repositioning + Helmet Therapy for Flat Head Syndrome

TG
Overseen ByTiffany Graham, MSPO
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Texas Southwestern Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores ways to assist babies with flat head syndrome. It tests whether changing a baby's position (Repositioning Therapy) can improve head shape and whether a special custom helmet (Cranial Remolding Orthosis) offers additional benefits. Babies with neck muscle tightness (torticollis) will receive physical therapy. Babies with an unusual head shape or frequent need for physical therapy might be suitable for this trial. Additionally, a group of healthy babies is being studied to observe natural head growth. As an unphased trial, this study provides a unique opportunity to enhance understanding and treatment of flat head syndrome in infants.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that these treatments are safe for infants?

Research shows that both repositioning therapy and helmets safely treat flat head syndrome in babies. Repositioning therapy involves changing the baby's position to help shape their head and is commonly used without major safety issues.

For helmets, studies have found them necessary and safe for babies with more noticeable head shape issues. Evidence supports their effectiveness and safety, with no major problems reported. Helmets are usually adjusted every few weeks and worn most of the day to help the head grow into the right shape.

Both treatments are well-tolerated. The FDA has approved helmet therapy for babies with unusual head shapes, further confirming its safety. Overall, both treatments are safe options for managing flat head syndrome in babies.12345

Why are researchers excited about this trial?

Researchers are excited about the trial for repositioning and helmet therapy for flat head syndrome because it explores a combined approach that might offer faster and more effective results. Traditionally, treatments for flat head syndrome include repositioning therapy, where infants are repositioned during sleep to encourage natural head shape correction, and cranial remolding orthoses, which involve wearing a custom-fitted helmet to guide skull growth. This trial investigates using both methods together, starting with repositioning therapy and transitioning to helmet therapy if needed. By doing this, the hope is to optimize skull growth and shape correction, potentially reducing the time infants need to wear helmets and improving overall outcomes.

What evidence suggests that repositioning therapy and cranial remolding orthosis are effective for flat head syndrome?

This trial will compare Repositioning Therapy alone with Repositioning Therapy combined with Cranial Remolding Orthoses for flat head syndrome. Studies have shown that repositioning therapy can correct flat spots on a baby's head by encouraging natural growth. This method involves changing the baby's position during sleep and play to relieve pressure on the flattened area. Research indicates that cranial remolding orthoses, or special helmets, effectively treat flat head syndrome, especially when used before the baby is 9 months old. These helmets gently shape the baby's head as it grows and are typically worn most of the day. Evidence supports both repositioning and helmets as effective treatments for flat head syndrome in babies.26789

Who Is on the Research Team?

TG

Tiffany Graham

Principal Investigator

University of Texas Southwestern Medical Center

Are You a Good Fit for This Trial?

This trial is for healthy infants with normal development who have flat head syndrome or torticollis but don't need physical therapy. Infants with abnormal head shapes, growth abnormalities, genetic conditions, or significant developmental delays requiring therapy cannot participate.

Inclusion Criteria

My infant is healthy with normal physical development and doesn't need physical therapy.

Exclusion Criteria

My child needs physical or occupational therapy due to developmental delays.
My infant has an abnormal head shape.
My infant has a genetic condition affecting their growth.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Repositioning Therapy

Infants begin repositioning therapy and physical therapy if torticollis is present. Follow-ups occur at least monthly.

2-4 months
Monthly visits (in-person)

Cranial Remolding Orthosis

Infants with unresolved head shape issues may opt for cranial remolding orthosis treatment, adjusted every few weeks.

Up to 8 months
Visits every few weeks (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment. Final evaluation at 12 months of age.

10 months after enrollment
Final visit at 12 months of age (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Cranial Remolding Orthosis
  • Repositioning Therapy
Trial Overview The study tests how well caregiver-led repositioning helps correct an infant's cranial shape and the effectiveness of a custom-made cranial remolding orthosis. It includes infants with torticollis receiving physical therapy and compares their growth to unaffected peers.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Repositioning Therapy + Cranial Remolding OrthosesExperimental Treatment2 Interventions
Group II: Repositioning TherapyExperimental Treatment1 Intervention
Group III: ControlActive Control1 Intervention

Cranial Remolding Orthosis is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Cranial Remolding Orthosis for:
🇪🇺
Approved in European Union as Cranial Remolding Orthosis for:
🇨🇦
Approved in Canada as Cranial Remolding Orthosis for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Texas Southwestern Medical Center

Lead Sponsor

Trials
1,102
Recruited
1,077,000+

Children's Health

Collaborator

Trials
8
Recruited
460+

Published Research Related to This Trial

Helmet therapy (DOC band) significantly reduced cranial vault asymmetry by 41.56% and cranial base asymmetry by 40.23% in infants with moderate to severe posterior deformational plagiocephaly, based on a study of 125 patients.
The timing of treatment initiation before 1 year of age did not significantly affect the outcomes, indicating that compliance with helmet usage was the key factor in achieving effective results.
Deformational posterior plagiocephaly: diagnosis and treatment.Teichgraeber, JF., Ault, JK., Baumgartner, J., et al.[2018]
Helmet molding therapy for deformational plagiocephaly significantly improves parents' perceptions of their children's head shape and ear position, with parent ratings increasing from an average of 2.99 to 7.88 for head shape and from 3.75 to 7.73 for ear position after treatment.
While parents perceive substantial improvements, actual measurements from topographic scans show only modest changes in head shape, indicating the importance of managing expectations for treatment outcomes among parents.
Treatment of plagiocephaly with helmet molding therapy: do actual results mimic perception?Katzel, EB., Koltz, PF., Sbitany, H., et al.[2011]
A systematic review of 15 studies indicates that cranial-molding orthosis (helmet) therapy leads to more significant and faster improvements in head shape for infants with positional plagiocephaly compared to conservative treatments, especially in cases of severe deformity.
The effectiveness of helmet therapy is enhanced when treatment begins early in infancy, although specific guidelines on the best timing and measurement criteria for treatment remain unclear.
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on the Role of Cranial Molding Orthosis (Helmet) Therapy for Patients With Positional Plagiocephaly.Tamber, MS., Nikas, D., Beier, A., et al.[2023]

Citations

A 10-Year Review of the Efficacy of Cranial Remolding ...Highlights · Cranial remolding orthoses (CROs) are an effective, evidence-backed treatment for isolated deformational plagiocephaly in infants.
Effectiveness of Helmet therapy for infants with moderate to ...Starting helmet treatment before 9 months and wearing it over 15 hours daily yielded better outcomes.
Therapeutic Effectiveness of a Novel Cranial Remolding ...This study aimed to evaluate the efficacy and safety of a novel cranial remolding helmet (baby band2) for positional plagiocephaly using 3D data ...
5. The Role of Cranial Molding Orthosis (Helmet) TherapyThe purpose of this systematic review is to address the clinical question: Does helmet therapy provide effective treatment for positional plagiocephaly? METHODS.
Cranial Remodeling - Medical Clinical Policy BulletinsAetna considers cranial remodeling bands (or helmets) as medically necessary orthoses for treatment of moderate-to-severe positional head deformities.
Effects of Initial Age and Severity on Cranial Remolding ...The aim of this study is to review the effects of an infant's presenting age and severity of deformation on cranial remolding orthotic (CRO) treatment outcomes.
A 10-Year Review of the Efficacy of Cranial Remolding ...Cranial remolding orthoses (CROs) are an effective, evidence-backed treatment for isolated deformational plagiocephaly in infants. Treatment efficacy has a ...
K 124023 - STARband® Cranial Orthosis - accessdata.fda.govThe STARband is designed to treat infants with abnormal head shapes from age 3 months to 18 months and is available by prescription only. Since ...
Cranial Remolding Orthosis (Helmets)The head is encouraged to grow into the lose areas of the helmet, allowing the flattened parts of the head to "catch up" with the prominent areas.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security